Carasent ASA Stock Nasdaq Stockholm
Stocks
CARAO
NO0010123060
Advanced Medical Equipment & Technology
OTC Markets Traded| Market Cap | 1.61B 166M 146M 136M 125M 235M 15.95B 238M 1.62B 632M 7.88B 624M 611M 27.22B | P/E 2026 * |
71.2x | P/E 2027 * | 28.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.61B 167M 147M 137M 125M 236M 16.01B 239M 1.62B 634M 7.9B 627M 613M 27.32B | EV / Sales 2026 * |
3.8x | EV / Sales 2027 * | 2.97x |
| Free-Float |
65.26% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Carasent ASA
| 1 day | -3.90% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.90% | -54.08% | - | - | 164M | |
| +4.41% | -1.49% | -33.04% | -2.10% | 30.25B | |
| -2.02% | -11.43% | -50.23% | +130.18% | 11.68B | |
| +2.11% | -0.37% | -26.73% | +60.69% | 5.28B | |
| +5.18% | +3.30% | - | - | 2.08B | |
| +1.20% | -8.25% | +46.76% | -32.79% | 1.86B | |
| +2.09% | +0.74% | - | - | 1.72B | |
| -0.08% | -3.34% | -39.62% | - | 1.03B | |
| +0.68% | 0.00% | +36.96% | +106.07% | 865M | |
| +4.75% | -0.90% | -43.32% | -54.47% | 723M | |
| Average | +1.47% | -3.45% | -15.60% | +34.60% | 6.17B | |
| Weighted average by Cap. | +2.60% | -3.99% | -32.50% | +34.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 424M 43.91M 38.6M 35.94M 33M 61.97M 4.21B 62.79M 427M 167M 2.08B 165M 161M 7.19B | 516M 53.39M 46.94M 43.69M 40.13M 75.35M 5.12B 76.34M 519M 203M 2.53B 200M 196M 8.74B |
| Net income | 24.2M 2.5M 2.2M 2.05M 1.88M 3.53M 240M 3.58M 24.36M 9.51M 119M 9.4M 9.2M 410M | 60.96M 6.31M 5.55M 5.16M 4.74M 8.9M 605M 9.02M 61.36M 23.96M 299M 23.68M 23.17M 1.03B |
| Net Debt | 5.87M 608K 534K 497K 457K 858K 58.29M 869K 5.91M 2.31M 28.78M 2.28M 2.23M 99.47M | -73.31M -7.59M -6.67M -6.21M -5.7M -10.71M -728M -10.85M -73.79M -28.82M -359M -28.48M -27.86M -1.24B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
